Why BCS

Most services add capacity. We add measurable outcomes.

Six reasons PCN Clinical Directors and ICB commissioners pick BCS over the alternative.

The difference

Capacity vs. outcomes — why it matters.

A typical pharmacist-supply model gives you hours. What you do with those hours, and what they produce, is your problem.

BCS gives you a programme: a defined cohort, a defined intervention set, a monthly impact report, and a named QA lead. The unit of delivery is an outcome, not a timesheet.

  • Programme scope agreed up front
  • Monthly outcomes report — not just activity
  • QA signed-off before anything is reported
  • Built-in DES, IIF and QOF mapping
  • Named clinical and operational leads per PCN
  • Predictable, transparent contract pricing

What PCNs see in year one

The numbers that justify the contract.

>95%
High-risk monitoring compliance
35%
GP medicines workload reduced
−2.4
Avg. medicines stopped per polypharmacy review
100%
Monthly reports QA-signed

Who we work with

Built for PCN Clinical Directors and ICB commissioners.

We work directly with PCN Clinical Directors, Operational Managers and ICB medicines optimisation teams. Every BCS programme is shaped around local priorities before a contract is signed — there is no off-the-shelf package.

If you need to demonstrate measurable value to your board, your patients and your regulator, BCS is built for you.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call